Could Blockchain Ensure Integrity of Clinical Trial Data? Written on March 17, 2020 by Healthcanal Staff
Essential oil components can be tested as drug candidates Written on February 25, 2020 by Healthcanal Staff
Two UB centers create a new platform on neurotoxicology and drug testing based on stem cells Written on May 8, 2019 by Healthcanal Staff
New gene therapy to treat rare inherited blood condition Written on April 1, 2019 by Healthcanal Staff
Cryptographic protocol enables greater collaboration in drug discovery Written on October 22, 2018 by Healthcanal Staff
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases Written on September 25, 2018 by Healthcanal Staff
FDA approves treatment for two rare types of non-Hodgkin lymphoma Written on August 8, 2018 by Healthcanal Staff
First monoclonal antibody therapy for prevention of migraine Written on June 1, 2018 by Healthcanal Staff
Nanomedicine: Drugs Can Be Made ‘Smarter’ Using New Drug Design Technology Written on April 23, 2018 by Healthcanal Staff
Erectile Dysfunction Drugs May Help Treat Many Other Conditions Written on April 18, 2018 by Healthcanal Staff
FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia Written on April 17, 2018 by Healthcanal Staff
Scientists to Explore the ‘Dark Genome’ for New Drug Targets Written on February 24, 2018 by Healthcanal Staff
A Biological Approach to Precision Medicine Targets Endless Number of Diseases Written on February 1, 2018 by Healthcanal Staff
New enzyme replacement therapy to treat rare genetic disorder alpha-mannosidosis in children and adults Written on January 26, 2018 by Healthcanal Staff
Yale researchers propose new ways to select patients for clinical trials Written on January 25, 2018 by Healthcanal Staff
Imaging technique could be ‘new ballgame’ in drug development Written on January 2, 2018 by Healthcanal Staff
First paediatric medicine to treat rare hormonal disorder Written on December 16, 2017 by Healthcanal Staff
FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome Written on December 12, 2017 by Healthcanal Staff
Yeast can be engineered to create protein pharmaceuticals Written on December 11, 2017 by Healthcanal Staff
Breakthrough in live-cell imaging studies could lead to innovative drugs for a variety of human diseases Written on November 29, 2017 by Healthcanal Staff
Study Examines the Effects of a Marijuana Alternative Written on November 22, 2017 by Healthcanal Staff
New medicine for rare inflammatory condition of the oesophagus Written on November 10, 2017 by Healthcanal Staff
FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma Written on October 19, 2017 by Healthcanal Staff
FDA approves new treatment for adults with relapsed follicular lymphoma Written on September 15, 2017 by Healthcanal Staff
FDA approves first biosimilar for the treatment of cancer Written on September 15, 2017 by Healthcanal Staff
FDA approves Mylotarg for treatment of acute myeloid leukemia Written on September 1, 2017 by Healthcanal Staff
Researchers Describe Novel Reporter Proteins for Tracking Long Term Expression of Therapeutic Genes Written on July 11, 2017 by Healthcanal Staff
FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease Written on June 23, 2017 by Healthcanal Staff
